文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

产碳青霉烯酶克吕沃尔菌属的流行病学特征

Carbapenemase-producing Kluyvera spp.: epidemiology of an evolving species.
PubMed 文献 · J Infect Dis · 2026-09-28

该研究基于以色列国家碳青霉烯耐药肠杆菌目监测系统,回顾分析2008至2023年146例产碳青霉烯酶克吕沃尔菌属病例,并对22株可用分离株做药敏与全基因组测序。结果以K. ascorbata为主,KPC与NDM为主要碳青霉烯酶,碳青霉烯酶基因经IncC与Rep-A型质粒传播,病例数逐年增加。

要点

  • 绝大多数病例来自直肠筛查标本,仅1例来自血培养,提示定植为主。
  • KPC占67.1%、NDM占26.7%,优势菌种为K. ascorbata(60.3%)。
  • 碳青霉烯酶基因由IncC和Rep-A型质粒介导,存在水平转移风险。

核心结论

  • 产碳青霉烯酶克吕沃尔菌属病例逐年增加,传播部分呈克隆性,暴发与散发并存。
  • 克吕沃尔菌属可携带多种质粒介导的耐药基因包括碳青霉烯酶,可能水平转移至其他菌种。

研究设计与样本

  • 对以色列国家碳青霉烯耐药肠杆菌目监测系统2008至2023年报告的全部产碳青霉烯酶克吕沃尔菌属病例进行回顾性流行病学分析。
  • 对22株可用分离株进行抗菌药物敏感性试验与全基因组测序。
  • 院内获得病例被分类为散发或暴发的一部分。

主要发现

  • 2008至2023年共146例产碳青霉烯酶克吕沃尔菌属病例,其中145例来自直肠筛查样本、1例来自血培养。
  • 优势菌种为K. ascorbata(60.3%),其次为K. cryocrescens(24%)。
  • 常见碳青霉烯酶为KPC(67.1%)与NDM(26.7%)。
  • 41.1%的院内获得病例被归为暴发的一部分。
  • 所有完成表征的分离株均为多重耐药且至少产一种碳青霉烯酶,碳青霉烯酶基因传播由IncC与Rep-A型质粒驱动。

临床怎么用

  • 对碳青霉烯耐药肠杆菌目监测中检出的克吕沃尔菌属应关注碳青霉烯酶基因的质粒传播潜力。
  • 直肠筛查是发现产碳青霉烯酶克吕沃尔菌属定植的主要途径,院内获得病例需排查暴发。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Kluyvera spp. are increasingly recognised as significant pathogens in humans. Recent reports of carbapenemase-producing (CP) Kluyvera spp. raise a concern that they may be disseminating carbapenemases to other species undetected. Research on CP-Kluyvera spp. is scarce, and little is known about their characteristics. METHODS: We aimed to investigate the epidemiology of CP-Kluyvera spp. in Israel, characterise their antimicrobial resistance and examine mechanisms of transmission of carbapenemase genes. We performed a retrospective epidemiological analysis of all cases of CP-Kluyvera spp. reported to Israel's national surveillance system of carbapenem-resistant Enterobacterales from 2008 to 2023. Hospital-acquired cases were categorized as sporadic or part of an outbreak. Microbiological characterisation of 22 available isolates included antimicrobial susceptibility testing and whole genome sequencing. RESULTS: There were 146 cases of CP-Kluyvera spp. in 2008-2023. 145 were detected in rectal screening samples, and one in a blood culture. The dominant reported species was K. ascorbata (60.3%), followed by K. cryocrescens (24%). The common carbapenemases were KPC (67.1%) and NDM (26.7%). 41.1% of hospital-acquired cases were classified as part of an outbreak.All characterised isolates were multidrug-resistant and produced at least one carbapenemase. Spread of carbapenemase genes in Kluyvera spp. was plasmid-driven by IncC and by Rep-A type plasmids. CONCLUSIONS: Cases of CP-Kluyvera spp. increased annually. Spread of CP-Kluyvera was partially clonal, with both outbreaks and sporadic cases detected. We illustrated that Kluyvera spp. produce a variety of plasmid-borne ARGs, including carbapenemases, which could be horizontally transferred to additional bacterial species, revealing the increasing clinical significance of Kluyvera genus.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Levi GD, Lurie-Weinberger MN, Schwartz D, et al. Carbapenemase-producing Kluyvera spp.: epidemiology of an evolving species. J Infect Dis. 2026. PMID: 42804664. doi:10.1093/infdis/jiag468

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。